Patent details
EP2991999 Title: DAPAGLIFLOZIN LACTOSE CO-CRYSTAL
Basic Information
- Publication number:
- EP2991999
- PCT Application Number:
- IL2013051048
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP138833546
- PCT Publication Number:
- WO2014178040
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- DAPAGLIFLOZIN LACTOSE CO-CRYSTAL
- French Title of Invention:
- CO-CRISTAL DE DAPAGLIFLOZINE ET DE LACTOSE
- German Title of Invention:
- DAPAGLIFLOZIN LAKTOSE CO-KRISTAL
- SPC Number:
Dates
- Filing date:
- 23/12/2013
- Grant date:
- 08/05/2019
- EP Publication Date:
- 09/03/2016
- PCT Publication Date:
- 06/11/2014
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 08/05/2019
- EP B1 Publication Date:
- 08/05/2019
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 23/12/2019
- Expiration date:
- 23/12/2033
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 01/05/2019
- Name:
- Mapi Pharma Limited
- Address:
- 16 Einstein Street Weizmann Science Park P.O. Box 4113, 74140 Ness Ziona, Israel (IL)
Inventor
1
- Name:
- MAROM, Ehud
- Address:
- Israel (IL)
2
- Name:
- RUBNOV, Shai
- Address:
- Israel (IL)
Priority
- Priority Number:
- 201361816809 P
- Priority Date:
- 29/04/2013
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/70; A61P 3/10; C07H 7/04;
Publication
European Patent Bulletin
- Issue number:
- 201919
- Publication date:
- 08/05/2019
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|